\
&
Contact us
\
&
Contact us
This was 4 years ago
Locationvirtual
ProgrammesThe Big Science Business Forum is organised by 11 European Research Infrastructures (RIs) focused on technology. By organising a business oriented congress they aim to create a meeting point between RIs and industry. The second edition is postponed due to the coronavirus pandemic to 4-7 October 2022. In the run-up to the conference a webinar series is organised on the topic ‘A look into the future of Big Science infrastructures.’
Miniseries Episode #1: Strategic view, roadmaps and development programmes of astronomy research infrastructures
Miniseries Episode #2: Fusion: Strategies, roadmaps and development programmes
Miniseries Episode #3: High-Energy Accelerators and Synchrotrons: strategies, roadmaps and development programmes
All information on the webinars can be found on this webpage
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
